266 related articles for article (PubMed ID: 6526539)
1. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
[TBL] [Abstract][Full Text] [Related]
2. Buflomedil kinetics in patients with liver disease.
Rey E; D'Athis P; Richard MO; Guerre J; Dorfman P; Bercoff E; Olive G
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):408-14. PubMed ID: 3759277
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of buflomedil after intravenous and oral administration.
Rey E; Barrier G; d'Athis P; de Lauture D; Richard MO; Lirzin JP; Sureau C; Olive G
Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):437-41. PubMed ID: 7203720
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral cefatrizine in patients with impaired renal function.
Couet W; Fauvel JP; Laville M; Pozet N; Fourtillan JB
Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of iopentol in patients with chronic renal failure.
Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
Moukhtar I; Nawishy S; Sabbour M
Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
[TBL] [Abstract][Full Text] [Related]
8. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
Ohnhaus EE; Spring P; Dettli L
Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
[No Abstract] [Full Text] [Related]
9. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mecillinam after a single intravenous dose in patients with impaired renal function.
Moukhtar I; Nawishy S; Sabbour M
Int J Clin Pharmacol Res; 1987; 7(1):59-62. PubMed ID: 3583488
[TBL] [Abstract][Full Text] [Related]
11. A study of practolol elimination in all grades of chronic renal failure.
Kaye CM; Kumana CR; Franklin DA; Baker LR
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of alfentanil in chronic renal failure.
Chauvin M; Lebrault C; Levron JC; Duvaldestin P
Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of clodronate in renal failure.
Saha H; Castren-Kortekangas P; Ojanen S; Juhakoski A; Tuominen J; Tokola O; Pasternack A
J Bone Miner Res; 1994 Dec; 9(12):1953-8. PubMed ID: 7872061
[TBL] [Abstract][Full Text] [Related]
17. Butofilolol pharmacokinetics in chronic renal insufficiency.
Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].
Peters U; Grabensee B; Hausamen TU; Fritsch WP; Grosse-Brockhoff F
Dtsch Med Wochenschr; 1977 Jan; 102(4):109-15. PubMed ID: 832589
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
Nawishy S; Moukhtar I; Sabbour M
Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
